Initial platform
Planned large-volume IV fluids, subject to development, manufacturing readiness and regulatory approval.
Our Products
Biogenix’s initial product direction is centred on sterile intravenous fluids, followed over time by carefully selected generic injectable medicines. All products remain subject to technical development, manufacturing readiness and applicable regulatory approval.
Planned large-volume IV fluids, subject to development, manufacturing readiness and regulatory approval.
Selected generic injectable medicines, guided by clinical need and individual technical, commercial and regulatory assessment.
Additional sterile pharmaceutical products where technically, commercially and regulatorily justified.
Portfolio Introduction
The proposed initial portfolio brings together five large-volume parenteral categories. Selection reflects the company’s intended focus on essential hospital medicines while product development, presentation and manufacturing decisions continue.
No product shown on this page is presented as registered, approved, commercially manufactured or available for purchase.
Planned IV-Fluid Portfolio
The collection below is sourced from the website’s controlled product records. It provides development context only and contains no prescribing information.

Artwork status
The visual presents an initial portfolio direction only. Product selection, strengths, formulations, pack sizes, label statements and final artwork remain subject to technical, commercial and regulatory review. The products are not presented as registered, manufactured or available for purchase.
Planned sterile IV fluid
A planned category within the proposed initial sterile IV-fluid portfolio.
Planned sterile IV fluid
A planned category within the proposed initial sterile IV-fluid portfolio.
Planned sterile IV fluid
A planned category within the proposed initial sterile IV-fluid portfolio.
Planned sterile IV fluid
A planned category within the proposed initial sterile IV-fluid portfolio.
Planned sterile IV fluid
A planned category within the proposed initial sterile IV-fluid portfolio.
Future Portfolio Direction
Potential areas will require individual clinical, technical, market and regulatory assessment. The list does not represent a committed product pipeline.
Understanding Product Status
These definitions explain statuses the website may use over time. A status will be applied to a product only when it accurately reflects confirmed information.
Healthcare Professional Resources
This area is intended for approved product information, package inserts, medical-information enquiries, product availability information and safety notices. No approved resources are currently published.
Manufacturing Direction
Learn how Biogenix is approaching sterile manufacturing technology, process control and supporting capabilities.